Triamcinolone Acetonide (Glaukos Corporation)

曲安奈德 (Glaukos Corporation)

Report date: 2025/11/14 14:16:43

Base Information

Drug NameTriamcinolone Acetonide (Glaukos Corporation)
Drug Alias NameIVT NCE ConjugateGLK-411
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaukos Corp
China Registration ClassN/A

Develop Information

Active CompaniesGlaukos Corp
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A